CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 136 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04782154
NCT04782154N/ACompleted

Paceport Swan-Ganz Data Collection Study

Montreal Heart Institute·observational·Posted Mar 4, 2021·Updated Sep 2, 2022

In Brief

An observational study for Right Ventricular Dysfunction and 2 related conditions. Completed, enrolled 136 participants across 1 site.

Detailed Summary

RV dysfunction has been associated with increased mortality in the ICU and cardiac surgical patients. Thus, early identification of RV dysfunction at less severe stages will allow for earlier intervention and potentially better patient outcomes. However, so far, no studies have reported prospectively the prevalence of abnormal RV pressure waveform during cardiac surgery and in the ICU. Our primary hypothesis is that the prevalence of abnormal RV pressure waveform occurs in more than 50% of cardiac surgical patients throughout their hospitalization. Those patients with abnormal RV pressure waveform will be more prone to post-operative complications related to RV dysfunction and failure in the OR and ICU.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 4, 2021
Enrollment StartAug 9, 2021
Primary CompletionMar 1, 2022
Study CompletionApr 1, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.3 years ago